Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.

Biotechnology

Education

Fulcrum Therapeutics

Alex C. Sapir

Swathi Srivatsa

Bassel Iskandarani

Alan Musso

Iain Fraser

Jeff Jacobs

Mel Hayes

Mani Sundararajan

Curtis Oltmans

Kim Hazen

Scientific Research and Development

Operations and Development

Board Governance Team

Clinical Affairs Team

Leadership Team

Medical and Clinical Operations

Finance and Legal

Teams at Fulcrum Therapeutics